Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Using index funds to manage risk emphasizes broad diversification and low costs. These funds help smooth returns and reduce exposure to idiosyncratic losses.
27,240 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Campbell’s posts worst quarters as revenue and margins deteriorate across key segments. The company trims full-year t...
The idea of easier real estate deals may be returning. This guide lays out what to watch for in 2026 and practical st...
A small exodus of California's billionaires ahead of a proposed wealth tax could erase billions in expected revenue. ...
Northrop Grumman has surged in 2026 on a record backlog and strong cash flow, but a major program in limbo keeps inve...
A private luncheon for the largest holders of a Trump-themed memecoin is back at Mar-a-Lago, renewing headlines about...
A cultural meme is shaping money decisions in licensing, estate planning, and brand strategy. Here’s how chuck norris...
A new wave of exclusive 'coming soon' syndication and pre-marketing platforms is reshaping pre-market exposure in rea...
Ethereum sits around $2,170 as the scaling debate intensifies. Analysts warn that a fragmented L2 path and security c...
A growing cadre of traders argues XRP could hit $10 even as it trades around $1.42, sparking a debate about what a pr...
Fort Worth is reshaping the Dallas-Fort Worth housing map as growth spreads to western suburbs. Analysts say fort wor...